Suppr超能文献

相似文献

1
Arsenic: health effects, mechanisms of actions, and research issues.
Environ Health Perspect. 1999 Jul;107(7):593-7. doi: 10.1289/ehp.99107593.
2
Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites.
Toxicol Appl Pharmacol. 2001 May 1;172(3):249-61. doi: 10.1006/taap.2001.9157.
3
Arsenicosis: review of recent advances.
J Assoc Physicians India. 2010 Oct;58:617-24, 629.
4
Arsenic carcinogenesis in the skin.
J Biomed Sci. 2006 Sep;13(5):657-66. doi: 10.1007/s11373-006-9092-8. Epub 2006 Jun 29.
5
Arsenic, mode of action at biologically plausible low doses: what are the implications for low dose cancer risk?
Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):557-64. doi: 10.1016/j.taap.2005.01.048.
6
Implications of arsenic genotoxicity for dose response of carcinogenic effects.
Regul Toxicol Pharmacol. 1996 Apr;23(2):87-105. doi: 10.1006/rtph.1996.0031.
7
Research toward the development of a biologically based dose response assessment for inorganic arsenic carcinogenicity: a progress report.
Toxicol Appl Pharmacol. 2007 Aug 1;222(3):388-98. doi: 10.1016/j.taap.2007.03.021. Epub 2007 Mar 30.
8
Arsenite cocarcinogenesis: an animal model derived from genetic toxicology studies.
Environ Health Perspect. 2002 Oct;110 Suppl 5(Suppl 5):749-52. doi: 10.1289/ehp.02110s5749.
10
Arsenic exposure, genetic susceptibility and leukocyte telomere length in an Italian young adult population.
Mutagenesis. 2016 Sep;31(5):539-46. doi: 10.1093/mutage/gew017. Epub 2016 Apr 15.

引用本文的文献

2
Wild exhibits far lower arsenic accumulation and hepatorenal in mice compared to equivalent dose of inorganic arsenic.
Front Pharmacol. 2025 Jun 24;16:1625045. doi: 10.3389/fphar.2025.1625045. eCollection 2025.
6
Arsenic and Benzo[a]pyrene Co-exposure Effects on MDA-MB-231 Cell Viability and Migration.
Biol Trace Elem Res. 2025 Jan;203(1):178-186. doi: 10.1007/s12011-024-04170-z. Epub 2024 Apr 11.
7
Arsenic-induced prostate cancer: an enigma.
Med Oncol. 2024 Jan 6;41(2):50. doi: 10.1007/s12032-023-02266-5.
8
Arsenic in Drinking Water and Diabetes.
Water (Basel). 2023 May 1;15(9). doi: 10.3390/w15091751. Epub 2023 May 2.
9
Alleviation of arsenic-induced neurobehavioral defects with selenium in the larvae of Zaprionus indianus.
Naunyn Schmiedebergs Arch Pharmacol. 2024 Apr;397(4):2121-2132. doi: 10.1007/s00210-023-02746-5. Epub 2023 Oct 3.
10
Metal Load of Potentially Toxic Elements in Tuna ()-Food Safety Aspects.
Foods. 2023 Aug 12;12(16):3038. doi: 10.3390/foods12163038.

本文引用的文献

1
Drinking water arsenic in Utah: A cohort mortality study.
Environ Health Perspect. 1999 May;107(5):359-65. doi: 10.1289/ehp.99107359.
2
Low serum carotene level and increased risk of ischemic heart disease related to long-term arsenic exposure.
Atherosclerosis. 1998 Dec;141(2):249-57. doi: 10.1016/s0021-9150(98)00178-6.
3
Arsenic levels in drinking water and the prevalence of skin lesions in West Bengal, India.
Int J Epidemiol. 1998 Oct;27(5):871-7. doi: 10.1093/ije/27.5.871.
4
Lung cancer and arsenic exposure in drinking water: a case-control study in northern Chile.
Cad Saude Publica. 1998;14 Suppl 3:193-8. doi: 10.1590/s0102-311x1998000700021.
5
Enzymatic methylation of arsenic compounds. V. Arsenite methyltransferase activity in tissues of mice.
Toxicol Appl Pharmacol. 1998 Jan;148(1):65-70. doi: 10.1006/taap.1997.8306.
6
Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression.
Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10907-12. doi: 10.1073/pnas.94.20.10907.
9
Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity.
Annu Rev Pharmacol Toxicol. 1997;37:397-419. doi: 10.1146/annurev.pharmtox.37.1.397.
10
A physiologically based pharmacokinetic model for arsenic exposure. II. Validation and application in humans.
Toxicol Appl Pharmacol. 1996 Oct;140(2):471-86. doi: 10.1006/taap.1996.0244.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验